Randomized Drug Interaction Study of RO4929097 for Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 12 Feb 2016
At a glance
- Drugs RG 4733 (Primary) ; Dextromethorphan; Ketoconazole; Midazolam; Omeprazole; Rifampicin; Tolbutamide
- Indications Solid tumours
- Focus Pharmacokinetics
- 14 Jun 2012 Planned end date changed from 1 Oct 2012 to 1 Jul 2012 as reported by ClinicalTrials.gov.
- 14 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Oct 2010 New trial record